Future unrelated medical costs need to be considered in cost effectiveness analysis

Pieter van Baal, Alec Morton, David Meltzer, Werner Brouwer

Research output: Contribution to journalArticle

Abstract

New medical technologies that prolong life result in additional health care use in life years gained. Some of these costs in life years gained are considered to be related to the intervention while other costs are considered unrelated. Here, we argue that ignoring these so-called future medical costs in cost effectiveness analysis is contrary to common sense, results in lost health and fails to inform decision makers whom cost effectiveness is supposed to serve.
LanguageEnglish
JournalEuropean Journal of Health Economics
Early online date18 Apr 2018
DOIs
StateE-pub ahead of print - 18 Apr 2018

Fingerprint

Cost-Benefit Analysis
Costs and Cost Analysis
costs
medical technology
Technology
Delivery of Health Care
Health
decision maker
Medical costs
Cost-effectiveness analysis
health care
health
Costs
Medical technology
Cost-effectiveness
Common sense
Healthcare
Decision maker

Keywords

  • health care expenditure
  • cost effective
  • future medical costs

Cite this

@article{e2450932c9c641cfa279984b802a9266,
title = "Future unrelated medical costs need to be considered in cost effectiveness analysis",
abstract = "New medical technologies that prolong life result in additional health care use in life years gained. Some of these costs in life years gained are considered to be related to the intervention while other costs are considered unrelated. Here, we argue that ignoring these so-called future medical costs in cost effectiveness analysis is contrary to common sense, results in lost health and fails to inform decision makers whom cost effectiveness is supposed to serve.",
keywords = "health care expenditure, cost effective, future medical costs",
author = "{van Baal}, Pieter and Alec Morton and David Meltzer and Werner Brouwer",
year = "2018",
month = "4",
day = "18",
doi = "10.1007/s10198-018-0976-0",
language = "English",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer",

}

Future unrelated medical costs need to be considered in cost effectiveness analysis. / van Baal, Pieter; Morton, Alec; Meltzer, David; Brouwer, Werner.

In: European Journal of Health Economics , 18.04.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Future unrelated medical costs need to be considered in cost effectiveness analysis

AU - van Baal,Pieter

AU - Morton,Alec

AU - Meltzer,David

AU - Brouwer,Werner

PY - 2018/4/18

Y1 - 2018/4/18

N2 - New medical technologies that prolong life result in additional health care use in life years gained. Some of these costs in life years gained are considered to be related to the intervention while other costs are considered unrelated. Here, we argue that ignoring these so-called future medical costs in cost effectiveness analysis is contrary to common sense, results in lost health and fails to inform decision makers whom cost effectiveness is supposed to serve.

AB - New medical technologies that prolong life result in additional health care use in life years gained. Some of these costs in life years gained are considered to be related to the intervention while other costs are considered unrelated. Here, we argue that ignoring these so-called future medical costs in cost effectiveness analysis is contrary to common sense, results in lost health and fails to inform decision makers whom cost effectiveness is supposed to serve.

KW - health care expenditure

KW - cost effective

KW - future medical costs

UR - https://link.springer.com/journal/10198

U2 - 10.1007/s10198-018-0976-0

DO - 10.1007/s10198-018-0976-0

M3 - Article

JO - European Journal of Health Economics

T2 - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

ER -